| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.009 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |